In the United Arab Emirates, health workers can take a Covid-19 emergency vaccine pending trial

0
11

The UAE has issued emergency clearance to use a coronavirus vaccine. (Representative)

Dubai:

The United Arab Emirates issued emergency approval for the use of a coronavirus vaccine on Monday, six weeks after the human trials began in the Gulf Arab state.

A Phase III study of a COVID-19-inactivated vaccine developed by the state-owned Chinese pharmaceutical company Sinopham began in July in the United Arab Emirates and has yet to be completed.

“The vaccine will be available to our first defense heroes who are at greatest risk of contracting the virus,” the National Emergency Crisis and Disaster Management Authority said in a tweet.

The announcement comes amid a surge in new COVID-19 cases in the UAE, with 1,007 cases reported on Saturday, the highest since the pandemic began. There were 777 new cases on Monday.

Emergency use of the vaccine, which is still being tested, has been granted to 31,000 volunteers according to established criteria and after testing.

Mild and expected side effects occurred, but there were no serious side effects, the agency said with no indication. Thousands of people with chronic diseases who took part saw no complications.

Sinopharm received approval for the process in late June. The experimental vaccine passed Phase I and II clinical trials, where 100% of the volunteers produced antibodies after two doses in 28 days, according to a statement from the Abu Dhabi government in July.

According to the Centers for Disease Control, inactivated vaccines – made either with inactivated (killed) viruses or with a protein from the virus – are known and have been used against diseases such as influenza and measles.

Russia became the first country in the world to approve a coronavirus vaccine in less than two months of human testing in August.

(Except for the headline, this story was not edited by GossipMantri staff and published from a syndicated feed.)

LEAVE A REPLY

Please enter your comment!
Please enter your name here